bullish
ICHI: Terpene Products to Be the Key Highlight in 2Q21
We reiterate our BUY rating with a target price at Bt16.50, derived from 26.6xPE’21E which is equal to Asia-ex Japan consumer staple peer, slightly higher than ICHI’s 5-years average at 25.2xPE.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Pi Securities PCL, Thailand
Leading, full-service investment firm in Thailand
- ICHI: Disappointing 1Q22 Result Already in the Price13 May 2022
- ICHI: Strong Earnings Momentum with Attractive Dividend Yield10 Mar 2022
- ICHI: Bright Outlook in 2022 and Beyond03 Mar 2022
- ICHI: Terpene Products to Be the Key Highlight in 2Q2120 Apr 2021
- ICHI: First Mover in Hemp-Related Products04 Mar 2021
- ICHI: Healthy Earnings in 4Q20E and Fresh Outlook in 1H2126 Jan 2021
- ICHI: Fresh Outlook in 2021 Thanks to Functional Drinks19 Nov 2020
x